AVTherapeutics

About:

AVT develops cancer therapeutics and immunotherapeutic vaccines that can be used together with prevalent treatment modalities.

Website: http://avtherapeutics.com

Description:

AVT is primarily engaged in the business of developing Cancer Therapeutics and Immunotherapeutic Vaccines that can be used together with prevalent treatment modalities such as chemotherapy and radiation to treat active disease and to prevent metastases and recurrence.

Total Funding Amount:

$660000

Headquarters Location:

New York, New York, United States

Founded Date:

2011-01-01

Founders:

Number of Employees:

1-10

Last Funding Date:

2013-12-31

IPO Status:

Private

Industries:

© 2025 bioDAO.ai